BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20006851)

  • 1. Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
    Herrmann E; Trojan L; Becker F; Wülfing C; Schrader AJ; Barth P; Stöckle M; Hammerschmied CG; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Legal W; Wullich B; Bolenz C; Klein T; Noldus J; Bierer S; Hertle L; Brenner W; Roos F; Michel MS; Walter B; Wieland W; Gerss J; Otto W; Hartmann A
    J Urol; 2010 Feb; 183(2):460-6. PubMed ID: 20006851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
    Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
    J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
    Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
    J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does renal capsular invasion have any prognostic value in localized renal cell carcinoma?
    Süer E; Ergün G; Baltaci S; Bedük Y
    J Urol; 2008 Jul; 180(1):68-71. PubMed ID: 18485385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
    Ficarra V; Schips L; Guillè F; Li G; De La Taille A; Prayer Galetti T; Cindolo L; Novara G; Zigeuner RE; Bratti E; Tostain J; Altieri V; Abbou CC; Artibani W; Patard JJ
    Cancer; 2005 Sep; 104(5):968-74. PubMed ID: 16007683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
    Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
    Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.